- Correction
- Open access
- Published:
Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
Multidisciplinary Respiratory Medicine volume 14, Article number: 39 (2019)
The Original Article was published on 13 September 2019
Correction to: Multidiscip Respir Med (2019) 14:30
https://doi.org/10.1186/s40248-019-0192-5
After publication of the Original research article [1] it was brought to our attention that the sentence at the bottom of the section entitled Discussion (pag 6 of 9, just below Fig. 4) must be corrected as follows:
“In real life, DPIs are highly prescribed in Italian COPD patients being their prescription usually independent of their known basic characteristics and technical differences, such as the different number of main actions required for their actuation (7 for Breezhaler, 4 for Turbohaler, and 3 for the remaining devices),” and their intrinsic resistance, ranging from 0.017 kPa0.5 L/min to 0.039 kPa0 .5 L/min [28, 29].
Reference
Negro D, et al. Patients’ usability of seven most used dry-powder inhalers in COPD. Multidiscip Respir Med. 2019;14:30. https://doi.org/10.1186/s40248-019-0192-5.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1186/s40248-019-0192-5
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Dal Negro, R.W., Turco, P. & Povero, M. Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD. Multidiscip Respir Med 14, 39 (2019). https://doi.org/10.1186/s40248-019-0204-5
Published:
DOI: https://doi.org/10.1186/s40248-019-0204-5